Novel spirotropane compounds and methods for the modulation of chemokine receptor activity
Details for Australian Patent Application No. 2005313813 (hide)
International Classifications
Event Publications
21 June 2007 PCT application entered the National Phase
PCT publication WO2006/060919 Priority application(s): WO2006/060919
14 April 2011 Application Accepted
Published as AU-B-2005313813
11 August 2011 Standard Patent Sealed
5 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005313797-Signal peptides, nucleic acid molecules and methods of treatment
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser